TMCnet News
Research and Markets: Global Nuclear Medicine Radioisotopes Market - Analysis And Forecasts 2014-2019Research and Markets (http://www.researchandmarkets.com/research/48df5t/global_nuclear) has announced the addition of the "Global Nuclear Medicine Radioisotopes Market - Analysis And Forecasts (2014-2019)" report to their offering. The global technetium-99m market is expected to grow from an estimated $6.839 Billion in 2014 to $12.295 billion in 2019, at an estimated compound annual growth rate (CAGR) of 12.47% percent, and the global market is expected to grow from an estimated $1.233 billion in 2014 to $2.148 billion in 2019 with a CAGR of 11.71%. Major driving factors for the growth of the market are increasing demand of SPECT analysis in radiopharmaceuticals, development of better instrments, newer computer based procedures for image analysis and display, new 99mTc labeled agents for visualizing biologically significant events, increasing demand of PET analysis in radiopharmaceuticals, increasing use in clinical applications to study psychiatric disorders. Integration of X ray tomography (CT) into SPECT has recently emerged as a brilliant diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. However, some of the major constrains for the market are shorter half-life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues. Major players in the market GE Healthcare, Hologic Inc., Medix Inc., Naviscan Inc., Positron Corporation, Segami Corporation. Mergers and acquisitions of small and medium-sized manufacturers to enter in overseas market is a strategy adopted by multinational players. Key Topics Covered: 1. Introduction 2. Key Findings 3. Executive Summary 4. Market Overview 5. Market Segmentation 6. Competitive Landscape 7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/48df5t/global_nuclear |
